US 12404508
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
granted A61KA61K47/02A61K47/549
Quick answer
US patent 12404508 (Ketohexokinase (KHK) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K47/02, A61K47/549